Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer.
Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer.
复制标题
miR-486-5p 的下调通过靶向肺癌中的促肿瘤 ARHGAP5 促进肿瘤进展和转移
作者:
We have previously shown that miR-486-5p is one of the most downregulated micro RNAs in lung cancer. The objective of the study was to investigate the role of miR-486-5p in the progression and metastasis of non-small-cell lung cancer (NSCLC). We evaluated miR-486-5p expression status on 76 frozen and 33 formalin-fixed paraffin-embedded tissues of NSCLC by quantitative reverse transcriptase PCR to determine its clinicopathologic significance. We then performed function analysis of miR-486-5p to determine its potential roles on cancer cell migration and invasion in vitro and metastasis in vivo. We also investigated the target genes of miR-486-5p in lung tumorigenesis. miR-486-5p expression level was significantly lower in lung tumors compared with their corresponding normal tissues (P< 0.0001), and associated with stage (P= 0.0001) and lymph node metastasis of NSCLC (P= 0.0019). Forced expression of miR-486-5p inhibited NSCLC cell migration and invasion in vitro and metastasis in mice by inhibiting cell proliferation. Furthermore, ectopic expression of miR-486-5p in cancer cells reduced ARHGAP5 expression level, whereas miR-486-5p silencing increased its expression. Luciferase assay demonstrated that miR-486-5p could directly bind to the 3′-untranslated region of ARHGAP5. The expression level of miR-486-5p was inversely correlated with that of ARHGAP5 in lung tumor tissues (P= 0.0156). Reduced expression of ARHGAP5 considerably inhibited lung cancer cell migration and invasion, resembling that of miR-486-5p overexpression. miR-486-5p may act as a tumor-suppressor contributing to the progression and metastasis of NSCLC by targeting ARHGAP5. miR-486-5p would provide potential diagnostic and therapeutic targets for the disease.
登录
查看更多内容
影响因子:
64.8
作者:
Lu, J;Getz, G;Golub, TR
通讯作者:
Golub, TR
影响因子:
11.5
作者:
Oh, Hue-Kian;Tan, Angie Lay-Keng;Tan, Patrick
通讯作者:
Tan, Patrick
影响因子:
9.8
作者:
Bansal, Ajay;Lee, I. H.;Christenson, L. K.
通讯作者:
Christenson, L. K.
DOI:
10.1186/bcr2352
发表时间:
2009
期刊:
Breast cancer research : BCR
影响因子:
--
作者:
Heckman-Stoddard BM;Vargo-Gogola T;McHenry PR;Jiang V;Herrick MP;Hilsenbeck SG;Settleman J;Rosen JM
通讯作者:
Rosen JM
DOI:
10.1083/jcb.119.3.493
发表时间:
1992-11
期刊:
The Journal of cell biology
影响因子:
--
作者:
Gavrieli Y;Sherman Y;Ben-Sasson SA
通讯作者:
Ben-Sasson SA